Clinical Trial Update: An Open Label Dose Finding Study of PTT-4256 in Patients With Solid Tumours (RAISIC-1). [Phase 1, Phase 2]

View source ↗

Summary

An open-label dose-finding Phase 1/2 clinical trial of PTT-4256 in patients with advanced solid tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• PTT-4256

Snippet

Sponsor: Pathios Therapeutics Pty Ltd | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: RECRUITING